Haemonetics HAE Plasma — Cost of goods sold
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's plasma — cost of goods sold.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Haemonetics's plasma — cost of goods sold?
- Haemonetics (HAE) reported plasma — cost of goods sold of $54.39M in Q1 2026.
- How has Haemonetics's plasma — cost of goods sold changed year-over-year?
- Haemonetics's plasma — cost of goods sold increased by 14.9% year-over-year, from $47.33M to $54.39M.
- What is the long-term trend for Haemonetics's plasma — cost of goods sold?
- Over 3 years (2023 to 2026), Haemonetics's plasma — cost of goods sold has grown at a -5.6% compound annual growth rate (CAGR), from $254.47M to $214.14M.
- What does plasma — cost of goods sold mean?
- Includes the direct costs attributable to the production and delivery of products and services within the plasma segment. This metric is essential for calculating gross margin and assessing the efficiency of the segment's manufacturing and supply chain processes. Fluctuations in this metric often reflect changes in raw material costs or production volumes.